A 26-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Chronic Idiopathic Constipation (CIC) in Adults
A 26-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Chronic Idiopathic Constipation (CIC) in Adults
This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess the safety and efficacy of tenapanor (5 mg, 25mg, and 50 mg) in adult patients with Chronic Idiopathic Constipation (CIC) when administered twice daily for 26 consecutive weeks.
This study consists of a 2-week Screening period, followed by a 26-week randomized treatment period (RTP), and a 4-week treatment-free Safety Follow-up period.
After obtaining study informed consent from patients, the 2-week Screening period starts. Patients will be fully assessed for eligibility into the study. The assessments will include evaluation of inclusion/exclusion criteria, including medical histories, physical examination, vital signs, 12-lead electrocardiogram (ECG), and clinical laboratory tests.
Patients will also self-report, on information about the status of their constipation symptoms and severity via an electronic diary (eDiary). Patient compliance with the eDiary will be monitored to determine eligibility at the end of screening.
Eligible patients will be randomized (Visit 2) to receive tenapanor 5 mg BID (twice a day), 25 mg BID, 50 mg BID, or placebo for 26 consecutive weeks as the double-blind RTP. During this period, patients will continue recording daily assessments of constipation symptoms and weekly assessments of constipation severity in the eDiary. Patients will have return visits every two to six weeks at Weeks 2, 4, 8, 12, 16, 20 and 26(Visit 3-9) to undergo safety assessments.
Upon completion of the 26-week RTP, patients will be monitored for AEs (adverse events) during the 4-week treatment-free Safety Follow-up period and complete the Follow-up visit (Visit 10) at the end of this period to undergo safety assessments.
Inclusion Criteria:
Exclusion Criteria:
mtambongco@ardelyx.com(617) 875-7968
Foley, Alabama 36535, United States
glresearch5@gmail.com251-943-2980
North Little Rock, Arkansas 72117, United States
Miami Beach, Florida 33162, United States
New Port Richey, Florida 34652, United States
Town and Country, Missouri 63017, United States
Jackson, New Jersey 08724, United States
Somers Point, New Jersey 08244, United States
Morehead City, North Carolina 28557, United States
Winston-Salem, North Carolina 27103, United States
North Richland Hills, Texas 76180, United States
Charlottesville, Virginia 22911, United States
Newport News, Virginia 23606, United States
Joanne@thecenterforclinicaltrials.com228-388-3112
rruiz@azclinicaltrials.com
Evette@eliteclinicalstudies.com602-788-3437
jforeman@criofaz.com623-223-1580
mgallegos@delsolresearch.com520-481-8464
courtney@arkgi.net501-945-9300
aroobalingam@hopeclinical.com
jcolia@gwresearch.net619-585-8882
marilyn@gastrosb.com619-382-3315
imohabir@allianceclinicalnetwork.com310-878-2636 ext. 1706
gbarragan@omclinicaltrials.com
leesa@ctrsites.com916-434-8230
snissan@allianceclinicalnetwork.com
cratakonda@jointopo.com
Thy.Tran@prxclinical.com
alexandra@advresearch.org303-353-2660
rmg@jointopo.com303-722-8987
vanessa.sutton@tektonresearch.com
npelegrin@proactivecr.com954-938-2843
ccramos@waterwayresearch.com
ychaviano@valenciamedresearch.com
teresa@roviaclinical.com
nramirez@hcresearchfl.com
mmason@suncoastclinicalresearch.com727-849-4131
jkuerth@sensiblehealthcare.net407-654-2724
jpages@clinmastery.com305-957-7200
atiffany@suncoastclinicalresearch.com727-781-3655
zachary@floridacrc.com
mmendoza@agilecrt.com
mlaqua@delricht.com504-336-2667
Onichols@gigeorgia.com678-819-4237
shelby.satterwhite@ngclinicalresearch.com
bbates.ect@gmail.com208-643-0006
rdugdale@tvmedresearch.com
ansharah.asif@gialliance.com
pkalwajtys@cisresearch.com
harish.gundlapalli@avicennaclinical.com
galina@evanstonpremier.com
hhunziker@delricht.com504-336-2667
aalioto@delricht.com913-391-7188
brooke.carr@tektonresearch.com
jwalker@delricht.com
josornio@tandemclinicalresearch.com985-219-6501
bbolton@delricht.com225-412-0316
MMuli@tandemclinicalresearch.com504-934-8424 ext. 7048
ekrambeck@delricht.com504-336-2667
bbolton@delricht.com225-412-0316
jennifer.davidson@roviaclinical.com318-538-0085
woodholme@jointopo.com
hannah.sheets@elixiahealth.com413-305-1144
tmlbsct@gmail.com617-923-0328
Behang@med.umich.edu
alaque@delricht.com504-336-2667
Taleah.brown@kcri.health
achristian@delricht.com504-336-2667
k.moushey@stcharlesclinicalresearch.com636-477-6366
nhuddleston@delricht.com504-336-2667
Coby.Ayers@objective.health573-740-0800
mosullivan@pinnacleresearch.com702-631-5000
sruvalcaba@allianceclinicalnetwork.com702-680-1500
vcuevas@lvresearch.com702-790-9114
matt@advresearch.org801-409-2040
jcohen@tandemclinicalresearch.com
ASanchez@tandemclinicalresearch.com609-715-1244
vescudero@abqct.com505-224-7407 ext. 260
smahmood@nyscientific.net347-547-6972
jtark@drugtrialsamerica.com914-341-2346
Alexandra.Montoya@accellacare.com
brooke.shoffner@roviaclinical.com; bshoffner@coastalresearchnc.com910-500-3146
ariyannal@petersmedicalresearch.com336-883-9773
Crystal.Gann@centricityresearch.com252-222-5700 ext. 135
megan.kopp@accellacare.com919-783-4895
Alexandra.fleming@accellacare.com252-316-3100
Stacy.smith@accellacare.com
Amelia.Evans@accellacare.com
Paris.Bennett@Accellacare.com
kwilliams@lillestolresearch.com218-329-4531
rubins4@ccf.org
Cindy.ma@centricityresearch.com
jtidwell@remdavis.com614-487-2560
sprice@myhometownuc.com937-912-4364
ChristyD@greatlakesgastro.net440-205-1205 ext. 218
asmith@delricht.com918-932-2276
shawna.hennigh@tektonresearch.com405-594-7712
jessicaw@advresearch.org503-610-0033
heastridge@delricht.com
Emily.McCoy@coastalcarolinaresearch.com843-856-3784
Henry.gong@accellacare.com
rhales@delricht.com615-234-1655
aoakes@newphaseresearch.com865-200-8364
lori.bell@accellacare.com
iwoodspowell@cnshealthcare.com901-843-1045
cstanley@qualitymedicalresearch.com615-939-5226
jzepeda@allianceclinicalnetwork.com
jquemado@epicmedresearch.com425-326-0309
angel@3asites.com
t.melliza@nhmr-inc.com817-595-3399
mustafa@linqresearchllc.com281-916-4220 ext. 102
ngilani@delricht.com504-336-2667
mmageno@sunresearch.com210-227-1289
lsabido@horizoncrg.com281-841-5798
nephi@advresearch.org801-409-2040
ahanks@wasatchcrc.com801-288-0607
faith@advresearch.org801-409-2040
caryn@cvillemedresearch.com434-825-4554
mfronz1@hrhr-inc.com
agarmon@delricht.com504-336-2667